Introduction
Mating components include sensory stimulation, seminal plasma and spermatozoa. Either individually or collectively, these constituents impact the female physiology through their interaction with cells composing the female reproductive tract. It is now widely accepted that, independently of its fertilizing role, mating has physiological relevance as it affects at molecular and cellular levels the functioning of reproductive organs near or beyond to the site of insemination (Erskine 1995 , Robertson 2005 .
The relevance of mating-associated factors on the molecular and cellular changes occurring in the female reproductive organs is clearly illustrated by the fact that mating can regulate the role of oestradiol (E 2 ) and 2-methoxyestradiol (2ME) on the oviductal egg transport in the rat. In unmated rats, E 2 accelerates ovum transport via a nongenomic action that requires prior conversion of E 2 to 2ME and successive activation of oestrogen receptors (ERs), cAMP-PKA and PLC-IP3 signalling cascades in the oviduct (Orihuela et al. 2001 , 2003 . This is corroborated by the fact that 2ME accelerates oviductal egg transport in unmated rats, but not in mated rats (Parada-Bustamante et al. 2007 . Thus, mating shut down a nongenomic action of 2ME in the oviduct of unmated rats that is necessary to accelerate egg transport. In mated rats, E 2 accelerates embryo transport via a genomic action that does not require conversion of E 2 to 2ME but involve activation of the ER and signalling of connexin 43, s100g and endothelin in the oviduct , Parada-Bustamante et al. 2012 .
Female immune system can recognize and respond to mating-associated signals inducing an inflammatory response in the genital tract that involves secretion of granulocyte-macrophage colony-stimulating factor, interleukins and chemokines (O'Leary et al. 2004 , Robertson 2005 , Kapelnikov et al. 2008 . These effects may involve a direct interaction between the cells of the female reproductive tract and the different components of the seminal plasma and/or spermatozoa to modulate the immune system resulting in cellular and molecular changes along the female reproductive tract (reviewed in Sharkey et al. (2007) ). Tumour necrosis factor-a (TNF-a) is a cytokine associated with immune responses in the female genital tract (Tremellen et al. 1998 , Maisey et al. 2003 , Morales et al. 2006 . Furthermore, transcripts of TNF-a and their receptors are expressed in mice, bovine and human oviduct (Hunt et al. 1993 , Srivastava et al. 1996 , Wijayagunawardane et al. 2003 , Reyes et al. 2007 . Moreover, there are data showing that TNF-a could participate in reproductive functions including fertilization, embryo development and implantation (Rasmussen et al. 1999 , Lee et al. 2000 , Torchinsky et al. 2003 , Abdo et al. 2008 , Choo et al. 2011 . Herein, we determined whether TNF-a is associated with the effect of mating on the nongenomic action of 2ME in the rat oviduct. First, we measured the concentration of TNF-a in the oviductal fluid of unmated and mated rats. We also determined the effect of mating on the levels of mRNA for TNF-a and their receptors Tnfrsf1a and Tnfrsf1b in the endosalpinx and myosalpinx of the rat oviduct. The tissue distribution of TNFRSF1A and TNFRSF1B was then compared in the oviduct of unmated and mated rats. Finally, we determined whether 2ME accelerates oviductal egg transport in unmated rats previously treated with a local injection of recombinant TNF-a alone or in combination with a selective inhibitor of the NF-kB activity.
Results

Mating increased the concentration of TNF-a in the oviductal fluid
This experiment was designed to determine whether mating affects the level of TNF-a in the oviductal fluid. At 0000 h of day 1 of cycle, a total of 30 rats were kept isolated (unmated group) or caged with fertile males during 30 min (mated group), and 1, 3 or 6 h later, oviducts were excised and the oviductal fluid was obtained to measure the concentration of TNF-a as described in the Materials and Methods section. Replicas of this experiment are stated in Fig. 1 .
Results of this experiment are shown in Fig. 1 . In unmated rats, the amount of TNF-a in the oviductal fluid ranged from 0.12G0.04 to 0.18G0.05 pg/mg protein. In mated rats, the amount of TNF-a increased five to six times only 3 h after mating (0.72G0.1 pg/mg protein) whereas 1 and 6 h post-mating the amount of TNF-a was similar to unmated rats (1 h, 0.19G0.04 pg/mg protein and 6 h, 0.18G0.01 pg/mg protein).
Mating did not change the level of the transcripts of Tnf, Tnfrsf1a and Tnfrsf1b in the rat oviduct
This experiment determined whether mating changes the level of mRNA for Tnf-a (Tnf ) and their receptors Tnfrsf1a and Tnfrsf1b in the rat oviduct. A total of 60 rats on day 1 of cycle were kept isolated (unmated group) or caged with fertile males during 30 min (mated group), and 1, 3 or 6 h later, oviducts were excised and separated in endosalpinx and myosalpinx to measure the level of the transcripts as described. Replicas of this experiment are stated in Figs 2 and 3.
Expression of Tnf mRNA was not detected in the endosalpinx and myosalpinx of unmated and mated rats (data not shown). As a proof of the efficiency of the realtime-PCR for Tnf, we used the RNA from liver samples of unmated rats. A band of 180 bp was detected corresponding to Tnf as verified after sequencing it (data not shown). On the other hand, the mRNA levels of Tnfrsf1a and Tnfrsf1b were not different between the endosalpinx (Tnfrsf1a, 30G0.03-42G0.042 and Tnfrsf1b, 0.12G0.03-0.22G0.08) and myosalpinx (Tnfrsf1a, 22G4.8-30G5.6 and Tnfrsf1b, 0.32G0.08-0.61G0.24) of unmated and mated rats. However, it was clear that the transcript of Tnfrsf1a was more highly expressed than Tnfrsf1b in the oviducts of unmated and mated rats (Figs 2 and 3 ).
Mating did not change the tissue distribution of TNF-a receptors in the rat oviduct Here, we investigated the tissue distribution of TNFRSF1A and TNFRSF1B in the oviduct of unmated and mated rats. A total of 12 rats on day 1 of cycle were Rats at 0000 h of day 1 of the cycle were kept isolated as unmated group or caged with fertile males for 30 min as mated group, and 1, 3 or 6 h later, animals were autopsied to measure the amount of TNF-a in the oviductal fluid. This experiment consisted of five replicates. asb, P!0.05. Note a dramatical increase in the amount of TNF-a 3 h after mating.
kept isolated or caged with fertile males during 30 min, and 1 or 3 h later, oviducts were excised and processed by immunohistochemistry as described. Replicas of this experiment are stated in Figs 4 and 5. Immunoreactivity of TNFRSF1A and TNFRSF1B was detected in the endosalpinx and myosalpinx with no differences in their distribution between the oviducts of unmated and mated (Figs 4 and 5).
TNF-a blocks the 2ME-induced egg transport acceleration in unmated rats
As mating increases the level of TNF-a in the oviductal fluid, here we determined whether administration of TNF-a into the oviduct of unmated rats can block the effect of 2ME on the egg transport. A total of 60 animals on day 1 of cycle were injected with saline into one ovarian bursa and with TNF-a 0.16, 0.33 or 3.3 ng/ml in the contralateral bursa, and 12 h later, animals were s.c. injected with 2ME 100 mg or propylene glycol as vehicle. Twenty-four hours after 2ME or propylene glycol injections, egg transport was assessed as described in the Materials and Methods section. Replicas of this experiment are stated in Fig. 6 . In order to confirm that intrabursal injection of TNF-a was effective, another 18 animals on day 1 of cycle were injected with saline or TNF-a 0.16 ng/ml, and 0.5, 1 or 3 h later, oviducts were excised and NF-kBp50 immunoreactivity was assessed as described in the Materials and Methods section. The results are shown in Fig. 6 . In rats s.c. treated with propylene glycol (vehicle), the number of eggs recovered from the oviducts treated with saline (vehicle) was 5.2G 0.6-5.7G1.0 while in the contralateral oviducts treated with TNF-a ranged from 5.1G0.7 to 6.8G0.7. Treatment with 2ME reduced the number of eggs in the oviducts treated with saline (1.9G0.8-2.8G0.9) while TNF-a partially blocked the 2ME-induced egg transport acceleration in the contralateral oviducts treated with 0.16 ng/ ml (4.3G0.8) and 0.33 ng/ml (4.1G0.9), but not in the oviducts treated with 3.3 ng/ml (2.4G1.1). On the other hand, Fig. 7 shows that NF-kBp50 immunoreactivity was mainly detected in the cytoplasm of epithelial cells of the control group while TNF-a 0.16 ng/ml induced transient translocation of NF-kBp50 at 0.5 h of treatment, Rats at 0000 h of day 1 of the cycle were kept isolated as unmated group or caged with fertile males for 30 min as mated group, and 1, 3 or 6 h later, the endosalpinx and myosalpinx layers were separated from the oviducts to determine the Tnfrsf1b mRNA relative expression obtained through real-time PCR. The values were normalized to Gapdh. This experiment consisted of five replicates. No differences were found between treatment groups. suggesting that intrabursal treatment with TNF-a was effective to activate its canonical signalling pathway in the oviductal epithelial cells.
A selective inhibitor of NF-kB did not revert the effect of TNF-a on the 2ME-induced egg transport acceleration in unmated rats
This experiment was done to establish whether inhibition of the NF-kB signalling cascade in the oviduct blocks the effect of TNF-a on the egg transport acceleration following treatment with 2ME. A total of 20 animals on day 1 of cycle were divided into the following treatment groups: i) saline plus propylene glycol; ii) saline plus 2ME 100 mg; TNF-a 0.16 ng/ml plus 2ME and iii) TNF-a plus pyrrolidine dithiocarbamate (PDCT) 75 mg/ml plus 2ME. Propylene glycol or 2ME was injected 12 h after intrabursal injection of TNF-a or PDCT. Twenty-four hours after 2ME injection, egg transport was assessed as described in the Materials and Methods section. Replicas of this experiment are stated in Fig. 8 . TNFRSF1A is expressed in the endosalpinx and myosalpinx of the oviduct of unmated or mated rats. Representative photomicrographs from rat oviducts processed by confocal microscopy. Rats at 0000 h of day 1 of the cycle were kept isolated as unmated group (A and B) or caged with fertile males for 30 min as mated group (E and D), and 1 or 3 h later, oviducts were excised to detect expression of TNFRSF1A (green). Nuclei were stained with propidium iodide (red). Arrows point to immnunoreactivity obtained in the endosalpinx and myosalpinx with no differences between all groups. This experiment consisted of three replicates. Controls of the immunoreactivity were incubated with preimmune serum (C and F). e, endosalpinx; m, myosalpinx; l, lumen. Figure 5 TNFRSF1B is expressed in the endosalpinx and myosalpinx of the oviduct of unmated or mated rats. Representative photomicrographs from rat oviducts processed by confocal microscopy. Rats at 0000 h of day 1 of the cycle were kept isolated as unmated group (A and B) or caged with fertile males for 30 min as mated group (E and D), and 1 or 3 h later, oviducts were excised to detect expression of TNFRSF1B (green). Nuclei were stained with propidium iodide (red). Arrows point to immunoreactivity obtained in the endosalpinx and myosalpinx with no differences between all groups. This experiment consisted of three replicates. Incubating samples with preimmune serum assessed the specificity of immunoreactivity. (negative controls, C and F). e, endosalpinx; m, myosalpinx; l, lumen.
The results are shown in Fig. 8 . The number of eggs recovered from the oviduct of the control group (saline plus propylene glycol) was 10.2G1.1, while in the group treated with 2ME (saline plus 2ME) was 3.2G0.8. As previously shown, local administration of TNF-a (TNF-a plus 2ME) blocked the 2ME-induced egg transport acceleration (10.2G1.3) while PDCT (TNF-a plus PDCT plus 2ME, 7.7G1.4) did not revert this effect of TNF-a.
Discussion
The presence of cytokines has been demonstrated in the mammalian oviduct (Fahey et al. 2005 , Jiwakanon et al. 2010 , an important site of gamete transport, fertilization, early embryo development and egg transport (Croxatto 1996) . In contrast to other species (Hunt et al. 1993 , Srivastava et al. 1996 , Wijayagunawardane et al. 2003 , Reyes et al. 2007 ), we did not find expression of TNF-a mRNA in the endosalpinx and myosalpinx of the rat oviduct, indicating that the regulation of the transcription of the TNF-a mRNA in the mammalian oviduct could be species specific. However, the number of species studied in this regard is too small to formulate a phylogenetic based algorithm describing species specificity in the presence of the transcript for TNF-a in the mammalian oviduct.
Although mRNA for TNF-a is not expressed in the rat oviductal cells, we have found that TNF-a protein was dramatically increased in the oviductal fluid at 3 h after TNF-a blocks the 2ME-induced egg transport acceleration in unmated rats. Number of oocytes recovered from the oviducts of unmated rats on day 2 of the oestrous cycle. At 0060 h of the day 1 of the cycle, rats were injected with saline (vehicle) into one ovarian bursa and with TNF-a 0.16, 0.33 or 3.3 ng/ml in the contralateral bursa, and 12 h later, animals were s.c. injected with 2ME 100 mg or propylene glycol (vehicle). Twenty-four hours after 2ME treatment, egg transport was assessed. This experiment consisted of six replicates. asbsc, P!0.05. mating. How mating increase this cytokine in the oviductal fluid? We can speculate that some of the factors provided by mating such as the spermatozoids or sensory stimulation can interact on the uterine or vagina cells increasing the TNF-a release in these organs with the subsequent transport of TNF-a into the oviduct. Vascular connections between uterus and oviduct that facilitate the transport of several molecules along the reproductive tract may be responsible to transport TNF-a into the oviductal fluid (Bulletti et al. 1997) . The fact that TNF-a levels were increased only at 3 h after mating can be explained by a rapid TNF-a degradation in the oviductal fluid and also indicate that mating has a time of latency of 3 h to exert its effects on the oviduct. On the other hand, TNF-a receptors were expressed in the oviduct, although mating did change neither the TNF-a receptor transcript levels nor the localization of these receptors in the rat oviduct. The presence of both TNF-a receptors in the endosalpinx demonstrate a compatible localization with the increased level of TNF-a in the oviductal fluid and reinforce our hypothesis of a role of TNF-a in the effect of mating on the oviductal cells.
With the purpose of demonstrating that the increased amount of TNF-a in the oviductal fluid observed after mating is associated with the silencing of the 2ME nongenomic action that accelerates oviductal egg transport, we determined whether 2ME accelerates egg transport in unmated rats previously treated with an intrabursal injection of TNF-a. Our results showing that 2ME did no accelerate oviduct egg transport in unmated rats indicate that effectively TNF-a mimicked the effect of mating on the silencing of this 2ME nongenomic effect as previous works of our group have clearly established that 2ME does not accelerate egg transport in mated rats (Parada-Bustamante et al. 2007 . This suggests that TNF-a could be a key factor by which mating regulates the intraoviductal signalling of E 2 and 2ME relevant to control egg transport. On the other hand, the effect of exogenous TNF-a occurred at small concentrations similar to the detected in the oviductal fluid, suggesting that TNF-a uses a receptor with high affinity to block the effect of 2ME on egg transport. As both TNF-a receptors are expressed in the rat oviduct, the identity of the receptor that participates in this effect of TNF-a remains to be determined.
The TNF-a canonical signalling pathway involves activation of the transcription factor NF-kB on their target cells (reviewed in Heissmeyer et al. (1999) and Aggarwal (2003) ). In this context, we have also found translocation of the p50 subunit of NF-kB from the cytoplasm into the nucleus in oviductal epithelial cells from rats treated with TNF-a showing that the canonical pathway of TNF-a is active in the rat oviduct. However, inhibition of the NF-kB activity in the oviduct by administration of PDCT did not revert the effect of TNF-a on the 2ME-induced egg transport acceleration. Thus, TNF-a acts independently of the activation of NF-kB to shut down the nongenomic action of 2ME in the rat oviduct. As PDCT prevents activation of NF-kB by a mechanism that involves inhibition of I-kB degradation (Liu & Malik 1999) , we cannot determine which NF-kB subunit is effectively inhibited. It has been shown that NF-kB does not account for all the intracellular targets of TNF-a (MacEwan 2002 , Aggarwal 2003 . For example, TNF-a receptors can activate the Janus kinase or p38 pathways, as well as caspase signalling (Aggarwal 2003) . Furthermore, TNF-a stimulates adenylyl cyclase activity in human myometrial cells (Gogarten et al. 2003) , and in Jurkat lymphoblastic leukemia cells, TNF-a induced ceramide production that leads to enhance the growth of this cell line but is unable to activate NF-kB (Dbaibo et al. 1993) . Further studies are needed to determine whether some of these alternative pathways participate in the effect of TNF-a on the silencing of the nongenomic action of 2ME in the rat oviduct.
As we have previously demonstrated that the silencing of the intraoviductal 2ME nongenomic effect induced by mating involves inhibition of the catechol-Omethyltransferase (COMT) activity in the oviduct (Parada-Bustamante et al. 2007) , it is probable that TNF-a downregulate the COMT activity in the oviduct. According to this, Salama et al. (2009) have reported that in human endometrial cells, TNF-a increases the local biosynthesis of oestrogens while decreases the gene expression of Comt as a mechanism to prevent deleterious effects of cytokines in endometrium such as inflammation or endometrial cancer. Contrary to Salama et al. (2009) , Comt expression was upregulated by TNF-a in human myometrial cells in preparation for uterine contractions, labour and delivery (Wentz et al. 2006) . Thus, oestrogen metabolism dependent on TNF-a is v+v+v v+v+2ME TNF-α+v+ 2ME
TNF-α+ PDCT+2ME a a n =5 Figure 8 Inhibition of the NF-kB activity in the oviduct did not revert the effect of TNF-a on the 2ME-induced egg transport acceleration in unmated rats. Number of oocytes recovered from the oviducts of unmated rats following intrabursal injections of TNF-a 0.16 ng/ml and PDCT 7.5 mg/ml or saline (V) and a s.c. injection of 2ME 100 mg or propylene glycol (V) 12 h later. Twenty-four hours after 2ME treatment, egg transport was assessed. This experiment consisted of five replicates. asb, P!0.05.
influenced by the physiological context that occurs in the female reproductive tract.
There are scarce studies describing the role of TNF-a in he oviduct beyond inflammatory process. TNF-a has been associated with the cell and tissue damage observed in gonococcal salpingitis (McGee et al. 1992 , Morales et al. 2006 ). This damage is correlated with increased TNF-a release by epithelium cells of the human oviduct induced by gonococcal infection (McGee et al. 1992) . On the other hand, TNF-a stimulated secretion of the vascular endothelial growth factor by cultured human oviductal epithelial cells and stromal fibroblasts, which could be relevant to regulate oviductal fluid secretion necessary for preimplantation embryo development (Nasu et al. 2007) . Moreover, preimplantation bovine embryos express and release TNF-a in order to regulate the oviductal motility necessary for the transport of the embryo into the uterus at the optimal time for implantation (reviewed in Wijayagunawardane & Miyamoto (2004) ). Here, we describe a new physiological function of TNF-a in the mammalian oviduct associated with a change in the intraoviductal 2ME signalling induced by mating.
In summary, these results indicate that mating increases the TNF-a release into the oviductal fluid, although this is not associated with changes in the expression and localization of TNF-a receptors in the rat oviduct. Furthermore, TNF-a mimics the effect of mating on the 2ME-induced egg transport acceleration in unmated rats. It is concluded that TNF-a could be the signal by which mating shut down the intraoviductal 2ME nongenomic action that accelerates egg transport. These findings provide new evidence to understand the mechanism underlying the silencing of the 2ME nongenomic effect induced by mating in the oviduct and illustrate a new physiological role of TNF-a in the female reproductive tract.
Materials and Methods
Animals
Locally bred Sprague Dawley rats weighing 200-260 g were used. Animals were kept under controlled temperature (21-24 8C), and lights were on from 0700 to 2100 h. Water and pelleted rat chows were supplied ad libitum. The phases of the oestrous cycle were determined by daily vaginal smears (Turner 1961) , and all females were used after showing two consecutive 4-day cycles. To obtain unmated and mated rats, females at 0000 h of the day 1 of cycle were kept either isolated or caged with fertile males during 30 min. Then, isolated rats that presented cornified cells in the vaginal smear, a cell phenotype associated with ovulation, were designated as unmated rats, and those caged with fertile males that presented cornified cells and spermatozoa in the vaginal smear were designated as mated rats. The care and manipulation of the animals were done in accordance with the ethical guidelines of the Universidad de Santiago de Chile.
ELISA measurement of TNF-a levels
At 0000 h of the day 1 of cycle, animals were kept isolated as unmated group or caged with fertile males for 30 min (mated group), and 1, 3 or 6 h later, oviducts were excised and flushed with 50 ml saline solution in order to obtain the oviductal fluid. Levels of TNF-a were determined using a Rat TNF-a ELISA Ready-SET-Go (catalog no. 88-7340, eBioscience, San Diego, CA, USA). Protein concentration was assessed according Bradford (1976) using BSA as standard.
Treatments
Local administration of drugs
Unmated rats were injected in the ovarian bursa (intrabursal) with the drug described below. Control rats received the appropriate vehicle only. Rat recombinant TNF-a (BD Biosciences, San Jose, CA, USA) was injected into each ovarian bursa at a concentration of 0.16, 0.33 or 3.3 ng/ml in saline solution. The selective inhibitor of the NF-kB activity PDCT, Sigma Chemical Co.) was used at a concentration of 75 mg/ml dissolved in saline solution (Liu & Malik 1999) . All treatments were given at 0600 h of day 1 of cycle (oestrus day).
Systemic administration of 2ME
Unmated rats were injected s.c. with 100 mg 2ME (Steraloids, Newport, RI, USA) as a single dose in an injection volume of 0.1 ml propylene glycol. Control rats received propylene glycol alone. All treatments were given 12 h after local administration of drugs.
Animal surgery
Intrabursal administration of drugs, which minimizes the dose needed to affect the oviduct without systemic effects, was performed at 0600 h of day 1 of cycle (oestrus day) as described previously (Orihuela et al. 2001) . At this time, ovulation has already taken place, so this treatment cannot affect the number of oocytes ovulated.
Assessment of egg transport
Egg transport was evaluated as previously published (Orihuela et al. 2001 . Twenty-four hours after 2ME or vehicle treatment, animals were killed and their oviducts were flushed individually with saline. Flushing was examined under low-power magnification (25!), and the number of eggs found was recorded.
Real-time PCR
Oviducts were dissected in endosalpinx and myosalpinx and RNA was isolated using TRIzol Reagent (Invitrogen). Total RNA 1 mg of each sample was treated with DNase I Amplification grade (Invitrogen). The single-strand cDNA was synthesized by RT using the Superscript III Reverse Transcriptase First-Strand System for RT-PCR (Invitrogen), according to the 95-60 8C) . To verify specificity of the product, amplified products were subject to melting curve analysis as well as electrophoresis, and product sequencing was performed to confirm identity as described by Muscillo et al. (2001) . The expression of transcripts was determined using a method previously reported (Livak & Schmittgen 2001 , Parada-Bustamante et al. 2010 .
Immunofluorescence
Oviducts were fixed in cold 4% paraformaldehyde in PBS, pH 7.4-7.6, for 2 h and then a sequential transfer to 10% w/v sucrose in PBS for 60 min at 4 8C and 30% w/v sucrose in PBS at 4 8C overnight was done. Cryostat sections, 4-6 mm thick, were placed onto gelatin-coated slides and were blocked with 1% PBS-BSA for 120 min and then incubated with anti-TNFRSF1A (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-TNFRSF1B (Santa Cruz Biotechnology) or anti-NF-kBp50 (Santa Cruz Biotechnology) antibody 1:50 in 1% PBS-BSA in a humidified chamber overnight. Three PBS rinses were followed by 60-min incubation at room temperature with secondary antibody Alexa fluor 546-conjugated goat antirabbit IgG (Invitrogen) diluted in 1% PBS-BSA. Samples were subsequently washed with PBS, counterstained with 1 mg/ml propidium iodide and mounted in DABCO (Sigma). As negative controls, the primary antibody was replaced by preimmune serum. The resulting staining was evaluated using a Zeiss confocal laser-scanning microscope.
Statistical analysis
The results are presented as meanGS.E.M. Overall analysis was done by Kruskal-Wallis test followed by Mann-Whitney U test for pair-wise comparisons when overall significance was detected. The actual n value in the experiments that were performed to determine the effects of drugs on oviductal egg transport is the total number of rats used in each experimental group.
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